Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
|
|
The Wall Street Journal - Friday, 25 October 1996.
About 6,500 eligible Americans with hemophilia have decided to participate in the settlement plan, of whom about 800 had previously filed lawsuits against the companies. Meanwhile, about 550 eligible people with hemophilia decided to opt out of the class-action deal, of whom about 380 have filed lawsuits.
The companies in the proposed settlement, however, said they still will take a month to decide whether to stay in the settlement plan. A court hearing on the matter is set for late November in U.S. District Court in Chicago. The corporations tentatively participating in the settlement are Baxter International Inc., Bayer AG, Rhone-Poulenc Rorer Inc.'s Armour division and the Alpha Therapeutic unit of Green Cross Corp. of Japan.
961025
WJ961008
Copyright © 1996 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .